4.9 C
New York
Friday, February 23, 2024

Amgen Wins Big With FDA, Analyst Sees Soaring Potential

The FDA approval of Amgen, Inc’s (NASDAQ: AMGN) biosimilar version of Johnson & Johnson’s (NYSE: JNJ) psoriasis treatment, Stelara, for multiple …

This post was originally published on this site

Subscribe
Notify of
0 Comments
Inline Feedbacks
View all comments

Stay Connected

157,590FansLike
396,312FollowersFollow
2,280SubscribersSubscribe

Latest Articles

0
Would love your thoughts, please comment.x
()
x